This webinar will cover the following topics:
- How to adjudicate multiple stakeholder perspectives in first in human studies with constrained resources
- More dose levels, fewer patients, and the importance of bioanalysis
- Multiple hypotheses, multiple procedures: A seductive siren of complexity or a necessity of innovation?
- Easy to say, difficult to do: “Translational research” in orphan disease drug development